Loading...
Bioengineered AAV Capsids with Combined High Human Liver Transduction In Vivo and Unique Humoral Seroreactivity
Existing recombinant adeno-associated virus (rAAV) serotypes for delivering in vivo gene therapy treatments for human liver diseases have not yielded combined high-level human hepatocyte transduction and favorable humoral neutralization properties in diverse patient groups. Yet, these combined prope...
Na minha lista:
Udgivet i: | Mol Ther |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
American Society of Gene & Cell Therapy
2018
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5763027/ https://ncbi.nlm.nih.gov/pubmed/29055620 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2017.09.021 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|